WORXE Worlds Online Inc

Marimed’s Betty’s Eddies™ Brand Capturing Massachusetts Cannabis Market Share

Marimed’s Betty’s Eddies™ Brand Capturing Massachusetts Cannabis Market Share

  • Since April 2020, launch unit monthly sales increased 20X

  • Betty’s Eddies with its innovative and healthy formulations continues to be top selling edible brand with overwhelming positive reception across multiple consumer market segments

NORWOOD, Mass., Aug. 26, 2020 (GLOBE NEWSWIRE) -- (MRMD:OTCQX) (the “Company” or MariMed), a leading multi-state cannabis and hemp operator focused on health and wellness, announced today that Betty's Eddies™, one of its proprietary, in-house award-winning cannabis brands has seen its monthly unit sales increase 20X in Massachusetts alone since April 2020. Based upon the success of this brand in Illinois, Rhode Island, Maryland, and Nevada, MariMed is anticipating Betty’s Eddies to be the top selling edible in Massachusetts. MariMed’s strategic plan includes increasing the licensing and distribution of its top brands across strategic and high-growth medical and recreational markets in the U.S. and Puerto Rico.

One of the top performing cannabis brands in the United States, and the LeafLink Winner for Best Selling Medical Product in 2019, Betty's Eddies are gluten-free, vegan fruit chews made from organically grown fruits and vegetables. Containing full spectrum cannabis oil, they are available in a variety of flavors, including berry, orange, lemon, lime, grape, and peach mango.

Ryan Crandall, Chief Product Officer and Senior Vice President of Sales at MariMed, commented, "Infused cannabis products and edibles continue to grow in popularity across the U.S. with consumers looking for the highest quality ingredients, the best taste and flavors, and a consistent experience. We are very proud that Betty’s Eddies delivers on all those points, which is why the brand is experiencing such strong growth and an overwhelming positive response across multiple consumer segments in our markets. Bedtime Betty’s are especially in high demand. Consumers of all ages and segments are reporting positive relief from pain, insomnia, and nighttime disturbances.”

Recent reviewers shared their experiences:

"I tried these over the weekend and woke up an hour before my alarm, bright-eyed. There was no grogginess or “highover”, just a good mood and a readiness to tackle the day." - The Highest Critic 

"But something small, delicious, discreet, and quickly absorbed—like these downright artisanal fruit chews—actually provides a best-of-both-worlds option for those who want the grown-up benefits of therapeutic cannabinoids without surrendering all the fun of getting high off weed." - The Weed Eater 

"An edible that fits the needs of so many is incredibly juicy, delicious and potent! Our team recently had the opportunity to discover the Betty’s Eddies Multipack and the Bedtime Betty’s." - Cannapolitan Magazine

Bob Fireman, CEO of MariMed, Inc., said, "MariMed continues to focus on driving revenue by producing the highest quality products to be licensed and distributed in fast-growth state markets. We remain committed to developing new and innovative cannabis products to satisfy the needs of a growing consumer marketplace."

About MariMed:

MariMed Inc., a multi-state cannabis operator, is dedicated to improving the health and wellness of people through the use of cannabinoids and cannabis products. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. The Company is at the forefront of science and innovation through research developed by its lab technicians and medical advisors resulting in industry-leading products and brands, including "Betty's Eddies™”, “Nature’s Heritage™”, “Bourne Baking Co.", and “Kalm Fusion”. These precision dosed products are focused on specific symptoms and conditions and are licensed and distributed across the country.

For additional information, visit marimedinc.com.

Company Contact

Jon Levine, CFO

MariMed Inc.

Tel (781) 559-8713

Media Contact

Abigail Diehl

MariMed Inc.

Annie Graf

KCSA Strategic Communications

Investors

KCSA Strategic Communications

Scott Eckstein / Elizabeth Barker

EN
26/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed Extends Series B Preferred Stock Obligation Through 2031, Stre...

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today that it has entered into a Restructuring and Exchange Agreement (the “Agreement”) with the holders (the “Holders”) of its $14.725 million Series B Convertible Preferred Stock (the “Series B Obligation”). The restructuring extends the maturity of the Company’s obligations on favorable market term...

 PRESS RELEASE

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- . (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will...

 PRESS RELEASE

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s S...

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty The Brand’s First-Ever Swirled Chew Combines Strawberry and Chocolate Flavors Plus CBG and Horny Goat Weed for Libido-enhancing Fun NORWOOD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Betty’s Eddies is one of the top-selling and award-winning brands developed and d...

 PRESS RELEASE

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand ...

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrast...

 PRESS RELEASE

MariMed Statement on Historic Rescheduling of Cannabis

MariMed Statement on Historic Rescheduling of Cannabis NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Federal government officially a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch